Skip to main content
Top
Published in: Endocrine 2/2012

01-10-2012 | Original Article

Clinical–pathological changes in differentiated thyroid cancer (DTC) over time (1997–2010): data from the University Hospital “Maggiore della Carità” in Novara

Authors: L. Pagano, M. Caputo, M. T. Samà, V. Garbaccio, M. Zavattaro, M. G. Mauri, F. Prodam, P. Marzullo, R. Boldorini, G. Valente, G. Aimaretti

Published in: Endocrine | Issue 2/2012

Login to get access

Abstract

Differentiated thyroid cancer (DTC) is an important clinical entity in our population (Novara, Piedmont, Italy) which is characterized by important environmental influences, as iodine deficiency (ID) and subsequent supplementation, thyroiditis and occupational exposure. To evaluate the features of DTC in our population 20 years after the iodine-prophylaxis pondering the effects of the introduction of the new guidelines for diagnosis and management of DTC after 2005. 322 patients [244 females, age: mean (±SD) 53.8 ± 15.8 years] treated for DTC in a tertiary care center between 1997 and 2010 were retrospectively evaluated. Medical history, demographics, and pathological features were considered. Patients were subdivided into two groups: A (n = 139, diagnosis 1997–2005) and B (n = 183, diagnosis 2006–2010). The population of group A showed a mild ID, while normal iodine status was recorded in group B. A significant increase in histological tumor-associated thyroiditis was found from group A to B (p = 0.021). Recurrent or persistent diseases were found to be correlated with lymph nodes metastases and/or a distant disease at diagnosis, stimulated thyroglobulin levels at the first follow-up and an additional radioiodine therapy. Twenty percent of our patients were females employed in textile industries. The tumor-related inflammation and the occupational exposure should be considered as important factors in the pathogenesis of DTC. Further studies are required in order to confirm our findings.
Literature
1.
go back to reference J.A. Sipos, E.L. Mazzaferri, Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. 22, 395–404 (2010)CrossRef J.A. Sipos, E.L. Mazzaferri, Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. 22, 395–404 (2010)CrossRef
2.
go back to reference B.A. Kilfoy, T. Zheng, T.R. Holford et al., International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5), 525–531 (2009)PubMedCrossRef B.A. Kilfoy, T. Zheng, T.R. Holford et al., International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5), 525–531 (2009)PubMedCrossRef
5.
go back to reference F. Pacini, M.G. Castagna, L. Brilli et al., Differentiated thyroid cancer: ESMOClinical reccomendations for diagnosis, treatment and follow up. Ann. Oncol. 19(2), 99–101 (2008)CrossRef F. Pacini, M.G. Castagna, L. Brilli et al., Differentiated thyroid cancer: ESMOClinical reccomendations for diagnosis, treatment and follow up. Ann. Oncol. 19(2), 99–101 (2008)CrossRef
6.
go back to reference E.L. Mazzaferri, Managing low risk thyroid cancer. Endocr. Pract. 13(5), 499 (2007) E.L. Mazzaferri, Managing low risk thyroid cancer. Endocr. Pract. 13(5), 499 (2007)
7.
go back to reference D.E. Thompson, K. Mabuchi, E. Ron et al., Cancer incidence in atomic bomb survivors, part II: solid tumors, 1958–1987. Radiat. Res. 137, S17–S67 (1994)PubMedCrossRef D.E. Thompson, K. Mabuchi, E. Ron et al., Cancer incidence in atomic bomb survivors, part II: solid tumors, 1958–1987. Radiat. Res. 137, S17–S67 (1994)PubMedCrossRef
8.
go back to reference v. Gomez Segovia, H.J. Gallowitsch, E. Kresnik et al., Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984–2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14(4), 277–286 (2004)PubMedCrossRef v. Gomez Segovia, H.J. Gallowitsch, E. Kresnik et al., Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984–2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14(4), 277–286 (2004)PubMedCrossRef
9.
go back to reference A. Belfiore, G.L. La Rosa, G. Padova et al., The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 60, 3096–3102 (1987)PubMedCrossRef A. Belfiore, G.L. La Rosa, G. Padova et al., The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 60, 3096–3102 (1987)PubMedCrossRef
10.
go back to reference R.A. Ott, A.R. McCall, H. Jarosz et al., The incidence of thyroid carcinoma in Hashimoto’s thyroiditis. Am. Surg. 53, 442–445 (1987)PubMed R.A. Ott, A.R. McCall, H. Jarosz et al., The incidence of thyroid carcinoma in Hashimoto’s thyroiditis. Am. Surg. 53, 442–445 (1987)PubMed
11.
go back to reference G. Pellegriti, F. De Vathaire, C. Scollo et al., Papillary thyroid cancer incidence in the volcanic area of Sicily. J. Natl. Cancer Inst. 101, 1575–1583 (2009)PubMedCrossRef G. Pellegriti, F. De Vathaire, C. Scollo et al., Papillary thyroid cancer incidence in the volcanic area of Sicily. J. Natl. Cancer Inst. 101, 1575–1583 (2009)PubMedCrossRef
12.
go back to reference E.Y. Wong, R. Ray, D.L. Gao et al., Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shangai, China. Int. Arch. Occup. Environ. Health 79, 251–258 (2006)PubMedCrossRef E.Y. Wong, R. Ray, D.L. Gao et al., Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shangai, China. Int. Arch. Occup. Environ. Health 79, 251–258 (2006)PubMedCrossRef
13.
go back to reference WHO. Prevention and control of iodine deficiency disorders. Fifty-second world healthy assembly. Provisonal agenda item 13. Geneva; World Health Organization (1999) WHO. Prevention and control of iodine deficiency disorders. Fifty-second world healthy assembly. Provisonal agenda item 13. Geneva; World Health Organization (1999)
14.
go back to reference F. Pacini, M. Schlumberger, H. Dralle et al., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)PubMedCrossRef F. Pacini, M. Schlumberger, H. Dralle et al., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)PubMedCrossRef
15.
go back to reference D.S. Cooper, G.M. Doherty, B.R. Haugen et al., Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2), 109–141 (2006)PubMedCrossRef D.S. Cooper, G.M. Doherty, B.R. Haugen et al., Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2), 109–141 (2006)PubMedCrossRef
16.
go back to reference H. Gharib, E. Papini, R. Paschke, for the AACE/AME/ETA Task Force on Thyroid Nodules et al., American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association. Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr. Pract. 16(1), 1–43 (2010)PubMedCrossRef H. Gharib, E. Papini, R. Paschke, for the AACE/AME/ETA Task Force on Thyroid Nodules et al., American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association. Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr. Pract. 16(1), 1–43 (2010)PubMedCrossRef
17.
go back to reference American Joint Committee on Cancer: Chapter 8: Thyroid in: AJCC cancer staging handbook. 6th edition. Spinger, New York, pp 89–98 (2002) American Joint Committee on Cancer: Chapter 8: Thyroid in: AJCC cancer staging handbook. 6th edition. Spinger, New York, pp 89–98 (2002)
18.
go back to reference WHO, UNICEF, ICCIDD, Indicators for assessing iodine deficiency disorders and their control through salt iodination (World Health Organization, Geneva, 1992) WHO, UNICEF, ICCIDD, Indicators for assessing iodine deficiency disorders and their control through salt iodination (World Health Organization, Geneva, 1992)
19.
go back to reference American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper, D.S., Doherty, G.M., Haugen, B.R. et al. Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11): 1167-1214 (2009) American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper, D.S., Doherty, G.M., Haugen, B.R. et al. Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11): 1167-1214 (2009)
21.
go back to reference S. Lonati, A. Rapa, G. Di Dio et al., Iodine status in historically iodine deficiency area. Minerva Pediatr. 58(3), 255–256 (2006)PubMed S. Lonati, A. Rapa, G. Di Dio et al., Iodine status in historically iodine deficiency area. Minerva Pediatr. 58(3), 255–256 (2006)PubMed
22.
go back to reference L. Enewold, K. Zhu, E. Ron et al., Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol. Biomarkers Prev. 18, 784–791 (2009)PubMedCrossRef L. Enewold, K. Zhu, E. Ron et al., Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol. Biomarkers Prev. 18, 784–791 (2009)PubMedCrossRef
23.
go back to reference R. Elisei, E. Molinaro, L. Agate et al., Are the clinical and pathological features of differentiated thyroid carcinoma really changed over last 35 years? Study on 4187 patients from a single Italian Institution to answer to this question. J. Clin. Endocrinol. Metab. 95(4), 1516–1527 (2010)PubMedCrossRef R. Elisei, E. Molinaro, L. Agate et al., Are the clinical and pathological features of differentiated thyroid carcinoma really changed over last 35 years? Study on 4187 patients from a single Italian Institution to answer to this question. J. Clin. Endocrinol. Metab. 95(4), 1516–1527 (2010)PubMedCrossRef
24.
go back to reference M. Rizzo, R.T. Rossi, O. Bonaffini et al., Increased annual frequency of Hashimoto’s thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann. Endocrinol. (Paris) 71(6), 525–534 (2010)CrossRef M. Rizzo, R.T. Rossi, O. Bonaffini et al., Increased annual frequency of Hashimoto’s thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann. Endocrinol. (Paris) 71(6), 525–534 (2010)CrossRef
25.
go back to reference S. Benvenga, F. Trimarchi, Changed presentation of Hashimoto’s thyroiditis in north-eastern Sicily and Calabria (southern Italy) based on a 31-year experience. Thyroid 18(4), 429–441 (2008)PubMedCrossRef S. Benvenga, F. Trimarchi, Changed presentation of Hashimoto’s thyroiditis in north-eastern Sicily and Calabria (southern Italy) based on a 31-year experience. Thyroid 18(4), 429–441 (2008)PubMedCrossRef
26.
go back to reference G. Mazziotti, L.D. Premawardhana, A.B. Parkes et al., Evolution of thyroid autoimmunity during iodine prophylaxis—the Sri Lankan experience. Eur. J. Endocrinol. 149(2), 103–110 (2003)PubMedCrossRef G. Mazziotti, L.D. Premawardhana, A.B. Parkes et al., Evolution of thyroid autoimmunity during iodine prophylaxis—the Sri Lankan experience. Eur. J. Endocrinol. 149(2), 103–110 (2003)PubMedCrossRef
27.
go back to reference P. Vitti, E. Martino, F. Aghini-Lombardi et al., Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J. Clin. Endocrinol. Metab. 79(2), 600–603 (1994)PubMedCrossRef P. Vitti, E. Martino, F. Aghini-Lombardi et al., Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J. Clin. Endocrinol. Metab. 79(2), 600–603 (1994)PubMedCrossRef
28.
go back to reference F. Pacini, T. Vorontsova, E.P. Demidchik et al., Post Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and French. J. Clin. Endocrinol. Metab. 82(11), 3563–3569 (1997)PubMedCrossRef F. Pacini, T. Vorontsova, E.P. Demidchik et al., Post Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and French. J. Clin. Endocrinol. Metab. 82(11), 3563–3569 (1997)PubMedCrossRef
29.
go back to reference M.J. Favus, A.B. Scneider, M.E. Stachura et al., Thyroid cancer occurring as late as consequence of head-and-neck irradiation. Evaluation of 1056 patients. N. Engl. J. Med. 294, 1019–1025 (1976)PubMedCrossRef M.J. Favus, A.B. Scneider, M.E. Stachura et al., Thyroid cancer occurring as late as consequence of head-and-neck irradiation. Evaluation of 1056 patients. N. Engl. J. Med. 294, 1019–1025 (1976)PubMedCrossRef
30.
go back to reference L. García-Pascual, M.J. Barahona, M. Balsells et al., Complex thyroid nodules with nondiagnostic fine needle aspiration cytology: histopathologic outcomes and comparison of the cytologic variants (cystic vs. acellular). Endocrine. 39(1), 33–40 (2011)PubMedCrossRef L. García-Pascual, M.J. Barahona, M. Balsells et al., Complex thyroid nodules with nondiagnostic fine needle aspiration cytology: histopathologic outcomes and comparison of the cytologic variants (cystic vs. acellular). Endocrine. 39(1), 33–40 (2011)PubMedCrossRef
31.
go back to reference L. García-Pascual, M. Balsells, M. Fabbi et al., Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery Comparison with a control group. Endocrine 40(3), 423–431 (2011)PubMedCrossRef L. García-Pascual, M. Balsells, M. Fabbi et al., Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery Comparison with a control group. Endocrine 40(3), 423–431 (2011)PubMedCrossRef
32.
go back to reference D.T. Hughes, M.R. Haymart, B.S. Miller et al., The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21(3), 231–236 (2011)PubMedCrossRef D.T. Hughes, M.R. Haymart, B.S. Miller et al., The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21(3), 231–236 (2011)PubMedCrossRef
33.
go back to reference J.M. Stulak, C.S. Grant, D.R. Farley et al., Value of preoperative ultrasonography in surgical management of initial and reoperative papillary thyroid cancer. Arch. Surg. 141, 489–494 (2006)PubMedCrossRef J.M. Stulak, C.S. Grant, D.R. Farley et al., Value of preoperative ultrasonography in surgical management of initial and reoperative papillary thyroid cancer. Arch. Surg. 141, 489–494 (2006)PubMedCrossRef
34.
go back to reference T.Y. Ho, M.J. Liou, K.J. Lin et al., Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 40(2), 297–302 (2011)PubMedCrossRef T.Y. Ho, M.J. Liou, K.J. Lin et al., Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 40(2), 297–302 (2011)PubMedCrossRef
35.
go back to reference Y. Ito, T. Higashiyama, Y. Takamura et al., Risks factors for recurrence to the limph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J. Surg. 31, 2085–2091 (2007)PubMedCrossRef Y. Ito, T. Higashiyama, Y. Takamura et al., Risks factors for recurrence to the limph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J. Surg. 31, 2085–2091 (2007)PubMedCrossRef
36.
go back to reference E.L. Mazzaferri, S.M. Jhiang, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97, 418–428 (1994)PubMedCrossRef E.L. Mazzaferri, S.M. Jhiang, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97, 418–428 (1994)PubMedCrossRef
37.
go back to reference E. Sampson, J.D. Brierley, L.W. Le et al., Clinical management and outcome of papillary and follicular (differentiated thyroid cancer) presenting with distant metastasis at diagnosis. Cancer 110, 1451–1456 (2007)PubMedCrossRef E. Sampson, J.D. Brierley, L.W. Le et al., Clinical management and outcome of papillary and follicular (differentiated thyroid cancer) presenting with distant metastasis at diagnosis. Cancer 110, 1451–1456 (2007)PubMedCrossRef
38.
go back to reference M.G. Castagna, L. Brilli, T. Pilli et al., Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J. Clin. Endocrinol. Metab. 93(1), 76–81 (2008)PubMedCrossRef M.G. Castagna, L. Brilli, T. Pilli et al., Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J. Clin. Endocrinol. Metab. 93(1), 76–81 (2008)PubMedCrossRef
39.
go back to reference R.M. Tuttle, T. Hernan, J. Shas et al., Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by The New Thyroid Association Staging System. Thyroid 20(12), 1341–1349 (2010)PubMedCrossRef R.M. Tuttle, T. Hernan, J. Shas et al., Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by The New Thyroid Association Staging System. Thyroid 20(12), 1341–1349 (2010)PubMedCrossRef
Metadata
Title
Clinical–pathological changes in differentiated thyroid cancer (DTC) over time (1997–2010): data from the University Hospital “Maggiore della Carità” in Novara
Authors
L. Pagano
M. Caputo
M. T. Samà
V. Garbaccio
M. Zavattaro
M. G. Mauri
F. Prodam
P. Marzullo
R. Boldorini
G. Valente
G. Aimaretti
Publication date
01-10-2012
Publisher
Springer US
Published in
Endocrine / Issue 2/2012
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9612-4

Other articles of this Issue 2/2012

Endocrine 2/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.